1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR
GSK Plc - ADR
XNYS: GSK
Weak Stock
Download real time
47.020.42(0.90%)
5.9M
XNYS Volume

XNYS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

GSK PLC (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for GSK PLC (ADR) share price target, revenues, EPS, net income and more

GSK PLC (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue GSK PLC (ADR) Jun-2026 Quarterly Revenue is $8,409 Million which is growth of 5.3% YoY.

  • NEGATIVE

    Quarterly Net Profit GSK PLC (ADR) Jun-2026 Quarterly Net Profit is $435 Million which is growth of -69.9% YoY.

GSK Plc - ADR, Earnings Report - Quarterly Results, standalone, All financials are in GBP Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
8,4097,6298,6188,5477,9867,5168,1178,0127,8847,3638,0528,1477,178
Cost Of Rev.
2,2661,8752,6572,2582,1651,9372,5592,3972,1221,9702,4182,2721,932
Gross Profit
6,1435,7545,9616,2895,8215,5795,5585,6155,7625,3935,6345,8755,246
⌄
5,6623,4614,4553,6963,7983,3633,3415,4264,1163,9034,4613,9263,105
Operating Profit
4812,2931,5062,5932,0232,2162,2171891,6461,4901,1731,9492,141
⌄
-124-145-250-141-134-108-195-124-150-134-251-158-152
Profit Before Tax
3542,1449502,4561,8872,108563641,4951,3553791,7911,987
Tax
-19930522331224133662-1191274-19257242
⌄
4351,7376362,0131,4431,624414-581,1731,0463501,4641,624
Diluted NI Avail to Com Stockholders Ann.
4351,7376362,0131,4431,624414-581,1731,0463501,4641,624
Basic EPS
0.20.90.310.70.80.2-00.60.50.20.70.6
Diluted EPS After ExtraOrdinary
0.20.90.310.70.80.8-00.60.50.40.70.6
Number Of Shares End
2,0072,011.52,0092,0172,031.52,0442,0402,0402,039.52,034.52,0292,027.52,533.1
Net Income Continuing Discontinued Operations
4351,7376362,0131,4431,624414-581,1731,0463501,4641,624
Normalized Income
2,0281,8721,0262,2171,8901,8369462,0281,7711,7521,1732,0431,701
Interest Income
5822-74265054-28322432-382433
Interest
182167174167184162144156174166155182185
Net Interest Income
-124-145-250-141-134-108-195-124-150-134-251-158-152
EBIT
4782,2891,1982,5972,0212,2167351881,6451,4895721,9492,139
EBITDA
2,7682,7521,1983,3353,1803,0391,1471,1392,2842,0381,1952,5282,591
Reconciled Cost Of Rev.
2,2661,8752,6572,2582,1651,9372,5592,3972,1221,9702,4182,2721,932
Reconciled Depr.
2,290463-4067381,159823412951639549623579452
Profit From Continuing Operations
5531,8397272,1441,6461,772501651,3041,0813981,5341,745
Normalized EBITDA
2,8262,7741,1243,3613,2303,0932,5781,1712,3082,0701,6992,5522,624
*All financials are in GBP Million and price data in USD
Add metric to table
Search...

GSK PLC (ADR) competitor comparison and performance snapshot within industry

GSK PLC (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue GSK PLC (ADR) Dec-2025 Annual Revenue is $32,667 Million which is growth of 4.1% YoY.

  • POSITIVE

    Annual Net Profit GSK PLC (ADR) Dec-2025 Annual Net Profit is $5,716 Million which is growth of 122.0% YoY.

GSK Plc - ADR, Earnings Report - Annual Results, standalone, All financials are in GBP Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
3.7%
-0.9%
34,52332,66731,37630,32829,32434,11434,09933,75430,82130,18627,88923,923
Cost Of Rev. Ann.
-1.9%
-5.1%
9,0569,0179,0488,5659,55411,60311,70411,86310,24110,3429,2908,853
Gross Profit Ann.
6.2%
1.1%
24,14723,65022,32821,76319,77022,51122,39521,89120,58019,84418,59915,070
Operating Exp. Ann.
5.5%
-1.1%
17,27415,31216,78614,41813,04115,82816,17115,59913,51613,78312,57312,442
Operating Profit Ann.
7.4%
6%
6,8738,3385,5427,3456,7296,6836,2246,2927,0646,0616,0262,628
⌄
-
-
-660-633-603-735-826-754-850-840-728-667-662-650
Other Exp. Ann.
-
-
 -----------
PBT Ann.
9.6%
1.2%
5,9047,4013,4776,0645,6285,4426,9686,2214,8003,5251,93910,526
Tax Ann.
16.3%
13.9%
6411,1125267567073465809537541,3568772,154
⌄
-27.4%
-0.1%
4,8215,7162,5754,92814,9564,3855,7494,6453,6231,5329128,422
Diluted NI Avail to Com Stockholders Ann.
-27.4%
-0.1%
4,8215,7162,5754,92814,9564,3855,7494,6453,6231,5329128,422
EPS Ann.
-27.7%
-0.7%
 2.81.32.47.42.22.92.41.80.80.54.4
Diluted EPS Ann.
-27.3%
-0.7%
 2.81.22.47.32.22.92.31.80.80.54.3
Number Of Shares End
-0.1%
0.2%
 2,0092,0402,0292,0162,003.61,992.81,981.21,969.21,956.81,947.61,934.8
Total Exp. Ann.
2.5%
-2.7%
 24,32925,83422,98322,59527,43127,87527,46223,75724,12521,86321,295
Net Income Continuing Discontinued Operations Ann.
-27.4%
-0.1%
4,8215,7162,5754,92814,9564,3855,7494,6453,6231,5329128,422
Normalized Income Ann.
7.4%
3.9%
7,1436,9696,4976,2835,6255,6655,7696,1315,8695,4644,9783,658
Interest Income Ann.
21.8%
14.1%
32566048312629--637099
Interest Ann.
-6%
-4.3%
690687640725826777856885771736717735
EBITDA Ann.
6.5%
0.4%
10,05310,3466,6089,0358,5708,57010,1469,4407,4276,1204,36012,792
Reconciled Cost Of Rev. Ann.
-1.9%
-5.1%
9,0569,0179,0488,5659,55411,60311,70411,86310,24110,3429,2908,853
Reconciled Depr. Ann.
2.5%
-0.3%
3,0852,3142,5512,2942,1472,3772,3512,3341,8561,9221,7741,630
Profit From Continuing Operations Ann.
8.5%
-0.3%
5,2636,2892,9515,3084,9215,0966,3885,2684,0462,1691,0628,372
Normalized EBITDA Ann.
6.5%
4.4%
10,08510,7078,1279,6248,8749,1168,6148,7458,9948,0657,8604,357
*All financials are in GBP Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
4.1%
2Y CAGR
3.8%
3Y CAGR
3.7%
5Y CAGR
-0.9%
7Y CAGR
0.8%
10Y CAGR
3.2%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
122%
2Y CAGR
7.7%
3Y CAGR
-27.4%
5Y CAGR
-0.1%
7Y CAGR
6.7%
10Y CAGR
-3.8%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
-8.8%
2Y CAGR
3.1%
3Y CAGR
5.5%
5Y CAGR
-1.1%
7Y CAGR
1.8%
10Y CAGR
2.1%
Operating Expenses Annual Cr is falling faster than historical averages.

GSK PLC (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund GSK PLC (ADR) Dec-2025 Total Shareholders Fund is $16,377 Million which is growth of 19.8% YoY.

  • POSITIVE

    Total Assets GSK PLC (ADR) Dec-2025 Total Assets is $61,118 Million which is growth of 2.8% YoY.

GSK Plc - ADR, Balance Sheet, standalone, All financials are in GBP Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
0.5%
-5.3%
61,11859,46359,00560,14679,10380,43179,69258,06656,38159,08153,446
⌄
-3.4%
-5.4%
45,16246,37746,21050,05057,76159,62361,33554,39452,89254,11844,568
⌄
15.6%
2.3%
16,37713,67113,34710,59815,05514,58711,4054,360-681,1245,114
Total Capitalization Ann.
4.3%
-3.9%
30,39227,37427,50126,79234,81537,12533,98524,58714,15315,74420,391
Tangible Assets Ann.
-
-
-7,389-8,826-8,232-10,766-25,576-25,834-30,112-18,631-23,364-23,617-16,720
Working Capital Ann.
-
-
-----------
Invested Capital Ann.
-
-
-----------
Tangible Book Value Ann.
-
-
-7,389-8,826-8,232-10,766-25,576-25,834-30,112-18,631-23,364-23,617-16,720
Borrowings Ann.
-
-
-----------
Net Debt Ann.
-
-
-----------
Share Issued Ann.
0%
0%
4,315.54,314.34,312.24,311.34,309.64,308.24,306.54,303.34,2984,294.74,289.1
Number Of Shares End
-0.1%
0.2%
2,0092,0402,0292,0162,003.61,992.81,981.21,969.21,956.81,947.61,934.8
*All financials are in GBP Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
2.8%
2Y CAGR
1.8%
3Y CAGR
0.5%
5Y CAGR
-5.3%
7Y CAGR
0.7%
10Y CAGR
1.4%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-1.4%
2Y CAGR
0.8%
3Y CAGR
-2.1%
5Y CAGR
-0.7%
7Y CAGR
-0.7%
10Y CAGR
4.8%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
19.8%
2Y CAGR
10.8%
3Y CAGR
15.6%
5Y CAGR
2.3%
7Y CAGR
20.8%
10Y CAGR
12.3%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

GSK PLC (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share GSK PLC (ADR) Book Value Per Share is $11 which is growth of 30.5% YoY.

  • NEUTRAL

    ROE GSK PLC (ADR) ROE is 0% which is growth of 0% YoY.

GSK Plc - ADR, Ratios, standalone, All financials are in GBP Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-----------
ROE Ann. %
-
-
-----------
ROIC %
-
-
-----------
OPM Ann. %
3.6%
6.9%
25.52%17.66%24.22%22.95%19.59%18.25%18.64%22.92%20.08%21.61%10.99%
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
-----------
Working Capital Turnover Ann.
-
-
-----------
Quick Ratio Ann.
-
-
-----------
Current Ratio Ann.
-
-
-----------
Interest Coverage Ratio Ann.
-
-
-----------
LT Debt To Equity Ann.
-
-
-----------
*All financials are in GBP Million and price data in USD
Add metric to table
Search...

GSK PLC (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEUTRAL

    Cash From Operating Activity GSK PLC (ADR) Dec-2025 Cash From Operating Activity is $0 Million which is growth of 0% YoY.

  • NEUTRAL

    Net Cash Flow GSK PLC (ADR) Dec-2025 Net Cash Flow is $0 Million which is growth of 0% YoY.

GSK Plc - ADR, Cash Flow, standalone, All financials are in GBP Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-
-
-----------
⌄
-
-
-----------
⌄
-
-
-----------
Cash Plus Cash Eqv. End Of Year Ann.
-2.2%
-9.4%
3,2073,4032,8583,4253,8195,2624,8314,0873,6004,6055,486
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-177599-468-546-1,414470826479-905-1,1641,503
Cash Plus Cash Eqv. Begin Of Year Ann.
-3.8%
-6.8%
3,4032,8583,4253,8195,2624,8314,0873,6004,6055,4864,028
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-2,985-2,982-2,344-2,258-2,931-2,239-2,163-1,796-2,202-2,352-1,901
Issuance Of Capital Stock Ann.
-15.7%
-12.4%
1520102521295174568973
Issuance Of Debt Ann.
16%
-0.6%
3,1941,3412232,0463183,2987,88910,2192,2331,067-
Repayment Of Debt Ann.
-
-
-1,688-2,507-2,593-6,668-2,313-7,305-4,160-2,067-3,200-919-2,412
Repurchase Of Capital Stock Ann.
-
-
-1,377------65-74-99
Free Cash Flow Ann.
4.9%
-5.2%
4,0772,9403,6583,5284,2355,3384,9625,8593,9353,413-94
*All financials are in GBP Million and price data in USD
Add metric to table
Search...
×